However, despite the overwhelming evidence supporting blocking IFNAR in SLE, the fact that IFNAR is expressed by most cells of the body and stimulation contributes a wide array of anti-viral responses, suggests that IFNAR blockade could have unwanted side effects. This evidence concerns the gene IFNAR1 and systemic lupus erythematosus.